Improving the lives of people with Tourettes

An important focus of our research has been to understand how the brain networks that give rise to tics in Tourette syndrome could be effectively modified or controlled using non-invasive forms of brain stimulation so as to bring about a reduction in tics.
Girl using the Neupulse App and wearable wrist device
Tourettes Action Logo
This wearable and self-managing treatment could potentially change the lives of thousands of people living with Tourettes
Suzanne Dobson, ex Chief Executive of Tourettes Action
Neupulse App and wearable wrist device

About us

We will empower individuals with brain health conditions to have a choice over controlling their symptoms.

We use state-of-the-art brain imaging and brain stimulation techniques to investigate the neural processes that give rise to tics, the brain correlates of premonitory urges and the mechanisms of brain plasticity that might lead to the control or reduction of tics.

Get involved
We are looking for help  testing the Neutrack App
UK based volunteers wanted
We are looking for volunteers based in the UK to test the Neutrack App
Healthcare Professionals
The format of testing will be a 1h video call. We expect to run this testing at the end of May 2022 / June 2022

Our Solutions

Neupulse App
NeuTrack App
We are working on the development of a phone app that will monitor Tourette syndrome clinical symptoms over time as well as external factors that may influence these symptoms.
read more ->
Wearable
Wearable Wrist Device
In parallel to the trial, we will work on the development of a wearable wrist device that delivers median nerve stimulation at the press of a button with the aim to give people control of their tics.
read more ->
Research
We aim to understand how the brain networks that give rise to tics could be effectively modified or controlled using non-invasive forms of brain stimulation so as to bring about a reduction in tics.
read more ->

News

Frequently Asked Questions
An important focus of our research over the last few years has been to understand how the brain networks that give rise to tics could be effectively modified or controlled using non-invasive forms of brain stimulation so as to bring about a reduction in tics.
We estimate the device will be available within 3 years (by 2025). As the device will be a medical device regulated by medical device regulations this takes time to develop and validate. In addition there is the time required to have the product tested by independent testing houses to ensure that the device is safe and compliant with the standards

Our research suggests that the stimulation is suitable for anyone over 12 years of age. Additional research is currently being conducted to look at children who are younger than 12 years old

Our initial study demonstrated that stimulation was effective in reducing tic frequency in 75% of participants. The results of the clinical trial starting in 2022 will give a more accurate indication to the effectiveness of the technique.

We started the clinical trial in March 2022 and will run for approximately 10 months.

At the moment the clinical trial is full but there is a wait list that we can add your name to in case of any withdrawals. There are currently over 50 people on the wait list. The clinical trial is only open to people that live on the UK mainland (i.e. not Northern Ireland).

Unfortunately No. Our research investigating the use of median nerve stimulation to reduce tics in Tourette syndrome is a novel approach and there is currently no other clinical trials or similar research going on outside of the UK.

Most definitely. Our research team at the University of Nottingham is continuously conducting research aimed at understanding brain health conditions like Tourette syndrome and developing new treatment approaches. If you would like to volunteer to take part in these research studies, please take a look at the following link:

https://tsresearchuon.wixsite.com/jackson-lab

Company number: 13198315 

Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road
Nottingham 
England
NG7 2TU

Terms & Conditions
Cookies

Neupulse is a registered trade mark of Neurotherapeutics Ltd


Website by Clifton Media

Back to Top
crossmenu